Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

T-Bank to issue additional shares to convert Rosbank's shares

10/2/24 TCSG

Shareholders of EvroTrans approved dividends

10/2/24 EUTR

Magnit will open stores in the Magadan region

10/2/24 MGNT

TGC-14 invests about ₽40 billion in modernization of CHPP-2 in Ulan-Ude

10/2/24 TGKN

Shareholders of NOVATEK approved dividends

10/2/24 NVTK

TGC-14 set the SPO price

10/2/24 TGKN

Softline completes placement of additional share issue

10/2/24 SOFL

X5 Retail Group buys May24 marketplace

10/2/24 FIVE

Shareholders of Gazprom Neft approved dividends

10/1/24 SIBN

Shareholders of Udmurtneft approved dividends

10/1/24 UDMN